Literature DB >> 15365897

Intravenous valproate in acute adolescent mania: a preliminary report.

Anupam Thakur1, Siddhartha Dutta, Vinod K Sinha.   

Abstract

This study evaluated the efficacy and tolerability of intravenous valproate in acute mania in adolescents. Five consecutive patients, meeting the study criteria, were treated with intravenous valproate. Of them, three significantly improved and one had no appreciable improvement. Two out of five patients experienced gastrointestinal and neurological side effects. This preliminary study suggests intravenous valproate is useful and safe to treat acute juvenile mania.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365897     DOI： 10.1007/s00787-004-0360-8

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


  15 in total

1.  Intravenous valproate is well tolerated in unstable patients with status epilepticus.

Authors:  S Sinha; D K Naritoku
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

2.  Intravenous valproate treatment of severe manic symptoms after gastric bypass surgery: a case report.

Authors:  J Kaltsounis; O A De Leon
Journal:  Psychosomatics       Date:  2000 Sep-Oct       Impact factor: 2.386

3.  Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.

Authors:  D M Hilty; G D Rodriguez; R E Hales
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

Review 4.  Intravenous valproate in neuropsychiatry.

Authors:  J W Norton; E Quarles
Journal:  Pharmacotherapy       Date:  2000-01       Impact factor: 4.705

5.  The safety of rapid valproic acid infusion.

Authors:  N A Limdi; E Faught
Journal:  Epilepsia       Date:  2000-10       Impact factor: 5.864

6.  Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid.

Authors:  M G Chez; M S Hammer; M Loeffel; C Nowinski; B T Bagan
Journal:  J Child Neurol       Date:  1999-04       Impact factor: 1.987

7.  Acute antimanic efficacy and safety of intravenous valproate loading therapy: an open-label study.

Authors:  K Jagadheesan; Harpreet S Duggal; Subash Chandra Gupta; Somuya Basu; Sanjeev Ranjan; Rajiv Sandil; Sayeed Akhtar; S Haque Nizamie
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

Review 8.  Outcome in the pharmacologic treatment of bipolar disorder.

Authors:  P E Keck; S L McElroy
Journal:  J Clin Psychopharmacol       Date:  1996-04       Impact factor: 3.153

9.  Signs and symptoms of mania in pure and mixed episodes.

Authors:  F Cassidy; E Murry; K Forest; B J Carroll
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

10.  Intravenous valproate: a new perspective in the treatment of manic symptoms.

Authors:  Harpreet S Duggal; K Jagadheesan; Subhash Gupta; Soumya Basu; Sayeed Akhtar; Haque S Nizamie
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759
View more
  1 in total

Review 1.  Valproate use in children and adolescents with bipolar disorder.

Authors:  Jean Michel Azorin; Robert L Findling
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.